📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MedImmune

1.1 - Company Overview

MedImmune Logo

MedImmune

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biologics research and development as the global biologics research and development arm of AstraZeneca, developing medicines for unmet medical needs worldwide and pioneering innovative research and exploring novel pathways across key therapeutic areas including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; and neuroscience.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MedImmune

Codagenix Logo

Codagenix

HQ: United States Website
  • Description: Provider of live-attenuated viral vaccines and vaccine candidates, including CoviLiv (intranasal COVID-19, refrigerator-stable), CodaVax-RSV (genetically stable RSV), CodaVax-H1N1 (universal influenza), and vaccine candidates for yellow fever (modern production), dengue (tetravalent, balanced protection), and Zika. Designed to elicit broad antibody and T-cell responses with potential multi-season protection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Codagenix company profile →
Oncomatryx Logo

Oncomatryx

HQ: Spain Website
  • Description: Provider of biopharmaceutical precision drugs and diagnostic devices targeting the tumor microenvironment and stroma. Develops antibody-drug conjugates and human-derived proteins targeting peritumoral fibroblasts, endothelial cells, and extracellular matrix. Offerings include OMTX705 (FAP-targeting ADC), DMTX invaScan (COL11A1 IHC assay), and DMTX bladderScan (FGFR3 IHC assay).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncomatryx company profile →
BigHat Biosciences Logo

BigHat Biosciences

HQ: United States Website
  • Description: Provider of AI-guided antibody design and protein therapeutics via the Milliner platform integrating high-speed synthetic biology wet lab with machine learning to accelerate discovery and engineering; Reccy cloud-native LIMS/OS for instrument/robot control, scheduling, data management, and ML training; develops antibodies for oncology, inflammatory diseases, and immunology; partners with biopharma/biotech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BigHat Biosciences company profile →
Hibiskus Bio Logo

Hibiskus Bio

HQ: United States Website
  • Description: Provider of early-stage development of TIR-199, a small-molecule cancer therapy and potent proteasome inhibitor from the syrbactin natural product family, discovered by founders Profs. Pirrung and Bachmann of the University of California, Riverside (UCR) and Michigan.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hibiskus Bio company profile →
Apthera Logo

Apthera

HQ: United States Website
  • Description: Provider of peptide-based cancer immunotherapy solutions for the treatment of breast and prostate cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apthera company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MedImmune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MedImmune

2.2 - Growth funds investing in similar companies to MedImmune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MedImmune

4.2 - Public trading comparable groups for MedImmune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MedImmune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MedImmune

What does MedImmune do?

MedImmune is a provider of biologics research and development as the global biologics research and development arm of AstraZeneca, developing medicines for unmet medical needs worldwide and pioneering innovative research and exploring novel pathways across key therapeutic areas including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; and neuroscience.

Who are MedImmune's competitors?

MedImmune's competitors and similar companies include Codagenix, Oncomatryx, BigHat Biosciences, Hibiskus Bio, and Apthera.

Where is MedImmune headquartered?

MedImmune is headquartered in United States.

How many employees does MedImmune have?

MedImmune has 1,000 employees 🔒.

When was MedImmune founded?

MedImmune was founded in 2010 🔒.

What sector and industry vertical is MedImmune in?

MedImmune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MedImmune

Who are the top strategic acquirers in MedImmune's sector and industry

Top strategic M&A buyers and acquirers in MedImmune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MedImmune?

Top strategic M&A buyers groups and sectors for MedImmune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MedImmune's sector and industry vertical

Which are the top PE firms investing in MedImmune's sector and industry vertical?

Top PE firms investing in MedImmune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MedImmune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MedImmune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MedImmune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MedImmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MedImmune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MedImmune?

The key public trading comparables and valuation benchmarks for MedImmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MedImmune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MedImmune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MedImmune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MedImmune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MedImmune's' sector and industry vertical?

Access recent funding rounds and capital raises in MedImmune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MedImmune